Abstract

Willingness to pay for innovation: the case of the anti-HCV drugs from the Italian National Health Service perspective

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service
Patrizio Armeni ... Francesco Costa
Clinical Therapeutics | VOL. 42
Patrizio Armeni, et. al.Patrizio Armeni ... Francesco Costa
24 Jun 2020
Valutazione economica del sistema di aferesi per la rimozione di granulociti e macrofagi (Adacolumn®) rispetto a biologico nel trattamento della colite ulcerosa moderata-severa in pazienti steroido-dipendenti o resistenti in Italia
R Ravasio ... P Vernia
Giornale Italiano di Health Technology Assessment | VOL. 6
R Ravasio, et. al.R Ravasio ... P Vernia
30 Aug 2013
An economic evaluation of an abdominal aortic aneurysm screening program in Italy
Stefano Giardina ... Domenico Palombo
Journal of vascular surgery | VOL. 54
Stefano Giardina, et. al.Stefano Giardina ... Domenico Palombo
06 Aug 2011
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis
Carlo Lazzaro ... Luigi Angelillo
Expert review of pharmacoeconomics & outcomes research | VOL. ahead-of-print
Carlo Lazzaro, et. al.Carlo Lazzaro ... Luigi Angelillo
07 Jan 2023
View more papers

More From: Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish

Paper Title
Journal
Date
Author
Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview
Rosario Cultrera
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. -
Rosario CultreraRosario Cultrera
29 Jul 2024
The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI
Sergio Carbonara
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. -
Sergio CarbonaraSergio Carbonara
29 Jul 2024
Clinical pharmacy and telemedicine: an opportunity to improve epilepsy management.
Rossella Moscogiuri
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. 11
Rossella MoscogiuriRossella Moscogiuri
22 Jul 2024
The role of the hospital pharmacist to guarantee access and continuity of care for the management of epilepsy
Marcello Pani
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish | VOL. 11
Marcello PaniMarcello Pani
22 Jul 2024
View more papers